Effect of renal impairment on the pharmacokinetics of memantine.
Moritoyo T, Hasunuma T, Harada K, Tateishi T, Watanabe M, Kotegawa T, Nagai M, Kumagai Y, Fujitani T, Okura T, Fukuoka T, Miyoshi K, Matsuura B, Furukawa S, Kobori T, Moritoyo H, Nishikawa N, Tsujii T, Iwaki H, Nakamura M, Makino S, Ohnuma K, Yuji K, Hashimoto M, Takasu M, Hashizume Y, You K, Matsumura T, Tanaka Y, Matsumoto N, Nakamura J, Miura J, Akizawa T, Kitazawa K, Shibata T, Kuroki A, Honda H, Mukai M, Ohashi K, Morimoto T, Imai H, Okudaira T, Sato F, Imanaga J, Tanaka K, Nomoto M.
Moritoyo T, et al. Among authors: harada k.
J Pharmacol Sci. 2012;119(4):324-9. doi: 10.1254/jphs.12043fp. Epub 2012 Jul 21.
J Pharmacol Sci. 2012.
PMID: 22863669
Free article.
Clinical Trial.